| Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars | | |
| A qualitative study of interactions with oncologists among patients with advanced lung cancer | | |
| Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020 | | 2022 |
| Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics | | |
| Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017 | | 2022 |
| Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study | Journal of Cancer Research and Clinical Oncology | |
| Donepezil hydrochloride BCS class ambiguity: relevant aspects to be considered in drug classification | Journal of Pharmaceutical Sciences | 2022 |
| Cognitive impairment, perceived medication adherence, and high‐risk medication use in patients with reduced kidney function: A cross‐sectional analysis | Health Science Reports | 2022 |
| Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients | Scientific Reports | 2022 |
| Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology | British Journal of Cancer | |
| Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis | Neurological Sciences | |
| Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates | Korean Journal of Transplantation | 2022 |
| The Proportion of Randomized Controlled Trials That Inform Clinical Practice: A Longitudinal Cohort Study of Trials Registered on ClinicalTrials.gov | | |
| Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review. | Psychiatry Research | 2022 |
| The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis. | Orphanet Journal of Rare Diseases | 2022 |
| Trends in Use of High-Cost Antihyperglycemic Drugs Among US Adults with Type 2 Diabetes. | Journal of General Internal Medicine | 2022 |
| Orodispersible tablets for pediatric drug delivery: current challenges and recent advances | Expert Opinion on Drug Delivery | 2021 |
| Increasing Co-Pay Does Not Pay | Journal of Allergy and Clinical Immunology: in Practice | 2021 |
| Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US. | PLoS ONE | 2022 |
| Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. | JAMA Internal Medicine | 2022 |
| Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study. | Frontiers in Pharmacology | 2022 |
| Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea. | PLoS ONE | 2022 |
| A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety. | Frontiers in Cell and Developmental Biology | 2022 |
| Cancer Immunotherapies: What the Perioperative Physician Needs to Know. | Current Oncology Reports | 2022 |
| Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism. | Journal of Molecular Modeling | 2022 |
| Eye disorders associated with newer antiepileptic drugs: A real-world disproportionality analysis of FDA adverse event reporting system. | Seizure: the Journal of the British Epilepsy Association | 2022 |
| The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis. | Molecular Psychiatry | 2022 |
| Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis. | Endocrine | 2022 |
| Clinical Benefits of Switching from Original Infliximab to its Biosimilar (CT-P13) as a Potential TNF-α Inhibitor | Journal of Exploratory Research in Pharmacology | 2020 |
| Objective and subjective benefits of a psychiatric pharmacist-led long-acting injectable medication training at a large, multisite organization | Mental Health Clinician | 2020 |
| Clinical use of second-generation antipsychotics in children | Scandinavian Journal of Child and Adolescent Psychiatry and Psychology | 2017 |
| Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays | AAPS Journal | 2021 |
| A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials? | Translational Psychiatry | 2021 |
| Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium | Ophthalmic Surgery Lasers and Imaging Retina | 2019 |
| Insulin Storage: A Critical Reappraisal | Journal of Diabetes Science and Technology | 2021 |
| Facing small and biased data dilemma in drug discovery with federated learning | | |
| SGLT inhibitors as antidiabetic agents: a comprehensive review. | RSC Advances | 2020 |
| Preclinical challenges for developing long acting intravitreal medicines | European Journal of Pharmaceutics and Biopharmaceutics | 2020 |
| In-depth structural characterization of pentosan polysulfate sodium complex drug using orthogonal analytical tools | Carbohydrate Polymers | 2020 |
| Overview of Current Type I/II Kinase Inhibitors | | 2020 |
| An administrative fix for manufacturing process patent thickets | Nature Biotechnology | 2021 |
| Commercial Biomolecules | | 2021 |
| Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) | Drugs - Real World Outcomes | 2021 |
| Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study | Cancer | 2021 |
| The CredibleMeds list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information | British Journal of Clinical Pharmacology | 2021 |
| The effect of generic market entry on antibiotic prescriptions in the United States | Nature Communications | 2021 |
| Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration | JAMA Network Open | 2021 |
| Recent developments of HDAC inhibitors: Emerging indications and novel molecules | British Journal of Clinical Pharmacology | 2021 |
| A Comparison of Seizure Prophylaxis: Phenytoin Versus Levetiracetam | Cureus | 2021 |
| Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments | Frontiers in Molecular Biosciences | 2021 |
